(Q35168010)

6 August 2017

1 reference

title

Systemic therapy of advanced breast cancer (English)

1 reference

6 August 2017

Systemic Therapy of Advanced Breast Cancer (English)

1 reference

10.2165/00003495-199200444-00003

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199200444-00003

23 November 2023

1 reference

H. T. Mouridsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1283847

9 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1283847

9 September 2022

publication date

1 January 1992

1 reference

6 August 2017

1 reference

6 August 2017

volume

44 Suppl 4

1 reference

6 August 2017

page(s)

17-28; discussion 66-9

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199200444-00003

6 August 2017

exact match

0 references

cites work

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

1 reference

12 December 2020

Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial

1 reference

12 December 2020

Dose-response in the treatment of breast cancer: a critical review

1 reference

12 December 2020

Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group

1 reference

12 December 2020

Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors

1 reference

12 December 2020

Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer

1 reference

12 December 2020

Aminoglutethimide in the treatment of advanced breast cancer

1 reference

12 December 2020

Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer

1 reference

12 December 2020

A phase III clinical trial comparing the combination cyclophosphamide, adriamycin, cisplatin with cyclophosphamide, 5-fluorouracil, prednisone in patients with advanced breast cancer

1 reference

12 December 2020

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast

1 reference

12 December 2020

Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reduction

1 reference

12 December 2020

Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research

1 reference

12 December 2020

Pathological growth of androgen‐sensitive tissues resulting from latent actions of steroid hormones

1 reference

12 December 2020

High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer

1 reference

12 December 2020

Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study

1 reference

12 December 2020

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

12 December 2020

A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Aust

1 reference

12 December 2020

Aromatase inhibitors in the treatment of advanced breast cancer

1 reference

12 December 2020

A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer

1 reference

12 December 2020

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project

1 reference

12 December 2020

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

12 December 2020

CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.

1 reference

12 December 2020

Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B

1 reference

12 December 2020

A comparison of mitoxantrone and doxorubicin in breast cancer.

1 reference

12 December 2020

Progression from hormone dependence to autonomy in mammary tumors as an in vivo manifestation of sequential clonal selection

1 reference

12 December 2020

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

12 December 2020

Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination

1 reference

12 December 2020

Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research

1 reference

12 December 2020

Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast

1 reference

12 December 2020

High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association

1 reference

12 December 2020

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

1 reference

12 December 2020

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

1 reference

12 December 2020

A clinical trial of mitoxantrone (novantrone) versus doxorubicin (adriamycin) in combination chemotherapy for metastatic breast cancer

1 reference

12 December 2020

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma

1 reference

12 December 2020

A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer

1 reference

12 December 2020

A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations

1 reference

12 December 2020

A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group

1 reference

12 December 2020

Hormonal control of growth and progression in tumors of Nb rats and a theory of action

1 reference

12 December 2020

Mitomycin-C in breast cancer

1 reference

12 December 2020

Endocrine therapy of advanced breast cancer

1 reference

12 December 2020

Cancer of the breast: the past decade (second of two parts)

1 reference

12 December 2020

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

12 December 2020

Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day

1 reference

12 December 2020

An overview of megestrol acetate for the treatment of advanced breast cancer

1 reference

12 December 2020

Phase II evaluation of vindesine in patients with advanced breast cancer

1 reference

12 December 2020

New cytotoxic drugs in treatment of breast cancer

1 reference

12 December 2020

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial

1 reference

12 December 2020

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer

1 reference

12 December 2020

A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).

1 reference

12 December 2020

Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women

1 reference

12 December 2020

Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer.

1 reference

12 December 2020

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study

1 reference

12 December 2020

Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer

1 reference

12 December 2020

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

1 reference

12 December 2020

Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer. A collaborative North Central Cancer Treatment Group/Mayo Clinic phase II study

1 reference

12 December 2020

Estrogen receptor content and hormone-responsive growth of mouse mammary tumors

1 reference

12 December 2020

A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B study

1 reference

12 December 2020

Current status of epirubicin (Farmorubicin) in the treatment of solid tumours

1 reference

12 December 2020

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer

1 reference

12 December 2020

Cancer of the breast: the past decade (first of two parts).

1 reference

12 December 2020

Tamoxifen in advanced breast cancer

1 reference

12 December 2020

Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer

1 reference

12 December 2020

Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study

1 reference

12 December 2020

Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard

1 reference

12 December 2020

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

1 reference

12 December 2020

A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil, and either doxorubicin or epirubicin. French Epirubicin Study Group

1 reference

12 December 2020

10.2165/00003495-199200444-00003

Identifiers

DOI

0 references

Dimensions Publication ID

1011988771

0 references

1 reference